Umeclidinium
Once-daily inhaled LAMA for COPD, also in triple inhalers.
- Starts working
- Within 15 minutes
- Half-life
- About 11 hours
- In use since
- —
- Pregnancy
- Use with caution
Overview
Umeclidinium is a long-acting muscarinic antagonist used for COPD maintenance. It is available alone or combined with vilanterol or with fluticasone and vilanterol.
Conditions it's used for
How it works
Relaxes the airways by blocking a nerve signal that narrows them.
Umeclidinium belongs to the Long-acting antimuscarinics. How Long-acting antimuscarinics work: block the nerve signal that tightens airways and increases mucus.
Uses
- COPD maintenance
Available as: dry-powder inhaler.
Typical dose
- Adults
- 55 micrograms (1 inhalation) once a day.
Typical doses for orientation only. Your prescription, the pack leaflet and local guidance take priority.
Side effects
Common
Often mild and may settle with time
- Cough
- Sore throat
- Headache
- Constipation
Serious — get medical help
Uncommon, but need prompt attention
- Narrow-angle glaucoma worsening
- Urinary retention
- Fast heart rate
Warnings
- Not a rescue inhaler
Who should avoid it
- Narrow-angle glaucoma (caution)
- Urinary retention (caution)
Interactions
- Other anticholinergics — added effects
Other medicines in the atlas that need care with Umeclidinium, grouped by the reason:
High anticholinergic burdenModerateWith Amitriptyline, Atropine, Benzatropine, Chlorphenamine, Clomipramine and 20 more
Adding anticholinergic drugs increases dry mouth, constipation, urinary retention, blurred vision and confusion — and in older people, falls and possibly dementia risk.
What's usually done: Review whether both are needed; prefer alternatives in older adults.
Constipation, confusion and urinary retentionModerateWith Buprenorphine, Codeine, Fentanyl, Hydromorphone, Methadone and 6 more
Anticholinergics and opioids both slow the gut and bladder and can worsen confusion, especially in older adults.
What's usually done: Review whether both are needed; use bowel protection and monitor for retention or delirium.
Using it safely
- Alcohol
- Usually no problem in moderation. No specific interaction.
- Food and drink
- Not applicable.
- If you miss a dose
- Take when remembered; skip if near the next dose.
- Stopping it
- Symptoms may return.
- Driving
- Blurred vision may affect driving.
- Tests and checks
- Symptoms and exacerbations
- If too much is taken
- Dry mouth, fast pulse. Seek help.
- Storage
- Room temperature; use within 6 weeks of opening the tray.
- Legal status
- United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule HAustralia: Prescription only (Schedule 4)
Pregnancy and breastfeeding
Pregnancy
Use with caution
Limited data; use only if needed.
Breastfeeding
Use with caution
Limited data.
Special groups
- Kidney disease
- No adjustment.
- Liver disease
- No adjustment.
- Older adults
- Dry mouth and urinary effects are more common.
Brand names
- United States
- Incruse Ellipta, Anoro Ellipta, Trelegy Ellipta
- United Kingdom
- Incruse, Anoro, Trelegy
- India
- Incruse, Trelegy
- Australia
- Incruse Ellipta, Anoro, Trelegy
Examples only; many generic versions exist. The same brand name can mean different products in different countries.
Common questions
Do I need a prescription for Umeclidinium?
Yes — Umeclidinium is prescription-only in most countries.
Can I take Umeclidinium during pregnancy?
Use with caution. Limited data; use only if needed. Always check with a doctor or midwife.
How quickly does Umeclidinium work?
Within 15 minutes.
Related medicines
Tiotropium
Once-daily inhaler that keeps airways open in COPD.
RxWHOLong-acting antimuscarinicsGlycopyrronium
Once-daily inhaled bronchodilator for COPD.
RxLong-acting antimuscarinicsIndacaterol
Once-daily ultra-long-acting bronchodilator for COPD.
RxLong-acting beta agonistsIpratropium
Short-acting airway opener for COPD and asthma attacks.
RxWHOLong-acting antimuscarinics
Sources and official information
- MedlinePlus (US National Library of Medicine)
- DailyMed — official US labels
- NHS medicines A–Z
- WHO ATC/DDD index — R03BB07
Entry last reviewed October 2026. Compiled from WHO, NHS, FDA/DailyMed, BNF and national formulary information. How we write entries.